262 related articles for article (PubMed ID: 22317852)
41. Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis.
Ueda T; Sakagami T; Kikuchi T; Takada T
Respir Investig; 2018 Jan; 56(1):14-20. PubMed ID: 29325675
[TBL] [Abstract][Full Text] [Related]
42. Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease.
Tzelepis GE; Plastiras SC; Karadimitrakis SP; Vlachoyiannopoulos PG
Clin Exp Rheumatol; 2007; 25(5):734-9. PubMed ID: 18078622
[TBL] [Abstract][Full Text] [Related]
43. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
[TBL] [Abstract][Full Text] [Related]
44. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides.
Gayraud M; Guillevin L; Cohen P; Lhote F; Cacoub P; Deblois P; Godeau B; Ruel M; Vidal E; Piontud M; Ducroix JP; Lassoued S; Christoforov B; Babinet P
Br J Rheumatol; 1997 Dec; 36(12):1290-7. PubMed ID: 9448590
[TBL] [Abstract][Full Text] [Related]
45. Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy.
Ostojic P; Damjanov N
Clin Rheumatol; 2006 Nov; 25(6):819-21. PubMed ID: 16440134
[TBL] [Abstract][Full Text] [Related]
46. Early aggressive intra-venous pulse cyclophosphamide therapy for interstitial lung disease in a patient with systemic sclerosis. A case report.
Peshin R; O'Neill L; Browne P; O'Connell P; Kearns G
Clin Rheumatol; 2009 Jun; 28 Suppl 1():S31-4. PubMed ID: 19194736
[TBL] [Abstract][Full Text] [Related]
47. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
[TBL] [Abstract][Full Text] [Related]
48. Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study.
Furuya Y; Kuwana M
J Rheumatol; 2011 Oct; 38(10):2186-92. PubMed ID: 21885489
[TBL] [Abstract][Full Text] [Related]
49. Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FAST.
Fathi N; Furst DE; Clements PJ
Curr Rheumatol Rep; 2007 May; 9(2):144-50. PubMed ID: 17502045
[TBL] [Abstract][Full Text] [Related]
50. Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease.
Arunsurat I; Mahakkanukrauh A; Foocharoen C; Suwannaroj S; Nanagara R;
Clin Rheumatol; 2021 Jan; 40(1):205-211. PubMed ID: 32519048
[TBL] [Abstract][Full Text] [Related]
51. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.
Lê Thi Huong D; Papo T; Piette JC; Wechsler B; Blétry O; Lamas G; Baumelou A; Le Hoang P; Pennaforte JL; Valcke JC; Godeau P
Clin Exp Rheumatol; 1996; 14(1):9-16. PubMed ID: 8697666
[TBL] [Abstract][Full Text] [Related]
52. [A case of systemic sclerosis associated with interstitial pneumonia with various autoantibodies: improvement by intravenous cyclophosphamide therapy].
Ishiyama K; Suwa A; Ohta S; Moriguchi M; Suzuki T; Miyachi K; Hara M; Kashiwazaki S
Nihon Rinsho Meneki Gakkai Kaishi; 1996 Oct; 19(5):512-8. PubMed ID: 8952320
[TBL] [Abstract][Full Text] [Related]
53. The Safety of Intravenous Cyclophosphamide in the Treatment of Rheumatic Diseases.
Woytala PJ; Morgiel E; Łuczak A; Czesak-Woytala K; Wiland P
Adv Clin Exp Med; 2016; 25(3):479-84. PubMed ID: 27629736
[TBL] [Abstract][Full Text] [Related]
54. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
[TBL] [Abstract][Full Text] [Related]
55. [Interstitial pneumonia treated with intermittent cyclophosphamide pulse therapy].
Harada T; Takayama K; Kimotsuki K; Hidaka K; Miyazaki H; Kuwano K; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1221-6. PubMed ID: 8976077
[TBL] [Abstract][Full Text] [Related]
56. Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report.
Chinniah KJ; Mody GM
Afr Health Sci; 2017 Jun; 17(2):593-596. PubMed ID: 29062359
[TBL] [Abstract][Full Text] [Related]
57. Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
Moreno-Torres V; Martín-Iglesias D; Vivero F; González-Echavarri C; García-Moyano M; Enghelmayer JI; Malfante P; Gaser A; Ruiz-Irastorza G;
Semin Arthritis Rheum; 2023 Apr; 59():152164. PubMed ID: 36773521
[TBL] [Abstract][Full Text] [Related]
58. Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single centre's retrospective study.
Yuan J; Fang W; Zhang W; Ni Z; Qian J
Nephrology (Carlton); 2011 May; 16(4):440-5. PubMed ID: 21091923
[TBL] [Abstract][Full Text] [Related]
59. [A study on interval of intravenous cyclophosphamide pulse in the treatment of severe systemic lupus erythematosus].
Yang X; Yin P; Gao X
Zhonghua Nei Ke Za Zhi; 1996 Apr; 35(4):257-60. PubMed ID: 9387643
[TBL] [Abstract][Full Text] [Related]
60. Usefulness of Cyclophosphamide Pulse Therapy in Interstitial Lung Diseases.
Schupp JC; Köhler T; Müller-Quernheim J
Respiration; 2016; 91(4):296-301. PubMed ID: 27082957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
